首页 | 本学科首页   官方微博 | 高级检索  
     


HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg‐positive chronic hepatitis B patients
Authors:D. Wong  M. Littlejohn  L. Yuen  K. Jackson  H. Mason  J. Bayliss  G. Rosenberg  A. Gaggar  K. Kitrinos  M. Subramanian  P. Marcellin  M. Buti  H. L. A. Janssen  E. Gane  S. Locarnini  A. Thompson  P. A. Revill
Affiliation:1. Division of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia;2. Department of Gastroenterology, St. Vincent's Hospital, Melbourne, Vic., Australia;3. Gilead Sciences, Foster City, CA, USA;4. H?pital Beaujon, University of Paris, Clichy, France;5. Liver Unit, Vall d'Hebron (Ciberehd) University Hospital, Barcelona, Spain;6. Toronto Center for Liver Diseases, Toronto Western and General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada;7. New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号